A robot developed by Asan Medical Center (AMC)'s Institute of Biomedical Engineering is attracting attention after the hospital's cardiologists performed a successful heart stent procedure on a patient with angina using it.This marks a significant development in the domestic robotic surgical device
Lunit said it plans to supply Lunit INSIGHT CXR, its AI chest screening solution, to five major hospitals in Saudi Arabia.Lunit Insight CXR is software that utilizes AI-based technology to assist medical professionals by reading 10 chest diseases, such as lung nodules, lung hardening, and pneumothor
The government will launch an interagency council on "MyData" with the private sector to overhaul related laws and establish a medical data transmission system between transmitters and recipients by 2024. The authorities will also expand the scope of individuals’ medical data use.The Personal Inform
Tego Science has successfully demonstrated efficacy in a phase 3 clinical trial of its cell therapy for under-eye wrinkles, fulfilling the conditions for a full license. Tego Sscience's stock price surged to a daily permissible limit on Tuesday.Tego Science released the results of the domestic phase
VUNO said it has signed a memorandum of understanding (MOU) with Readycure, a dementia treatment medical device company based in Korea, to jointly research artificial intelligence (AI) medical solutions and develop medical devices for dementia treatment.Under the MOU, both companies plan to develop
The following article has been provided by Vetter Pharma International GmbH as part of its public relations activities. Korea Biomedical Review has no relationship with and bears no responsibility for the contents and opinions in it. – Ed.Due to growing demand for specialized treatments and increasi
Crohn's disease, an inflammatory bowel disease, was rare. However, it has been increasing recently, and there are estimated to be about 25,000 patients in Korea.Pediatric Crohn's disease accounts for about 20 percent of the total, with an estimated 5,000 children patients. Pediatric Crohn's disease
With the recent release of the results of the phase 3 studies -- KEYNOTE-859 and KEYNOTE-811 -- of the anti-PD-1 immunotherapy Keytruda (pembrolizumab), immunotherapy is becoming a backbone agent along with conventional chemotherapy in the first-line treatment of advanced gastric cancer, regardless
A research team at Seoul St. Mary's Hospital has presented a new direction for the treatment of acute and chronic graft-versus-host disease (GVHD), which occurs after allogeneic hematopoietic stem cell transplantation.Allogeneic hematopoietic stem cell transplantation is a primary method for treatin
ST Pharm, an affiliate of Dong-A Socio Group, said it would voluntarily withdraw its investigational new drug (IND) application for STP2250, an mRNA-based Covid-19 prevention booster vaccine, for phase 1/2a clinical trials.The company made this decision due to two main factors: the challenge of recr
Celltrion Group said the exercise amount for the share buy-back related to the appraisal right for the merger of Celltrion and Celltrion Healthcare totaled 7.9 billion won ($5.9 million) combined for both companies.The shares tallied due to the appraisal right were approximately 41,972 shares (about
Huons Global reported consolidated sales of 190.6 billion won ($142.9 million) and operating income of 31.9 billion won ($24 million) for the third quarter of this year, up 13.8 percent and 75 percent, respectively, from the same period last year. The group's performance was driven by increased inte
GC said it has signed a contract manufacturing organization (CMO) contract for Euvichol, an oral cholera vaccine developed by EuBiologics Co.Under the agreement, GC will be responsible for the contract manufacturing of the finished drug product (DP) of Euvichol until 2026. The two companies also set
Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, announced on Tuesday that its 3D Breast Tomosynthesis (DBT) AI solution, Lunit INSIGHT DBT, has received U.S. FDA 510(k) clearance.This approval signifies a major step forward in the fight against breast cancer, enabl
VUNO, a medical artificial intelligence company, reported consolidated sales of 3.6 billion won ($2.7 million) in the third quarter, jumping 330 percent year-on-year from 840 million won ($636 thousand) a year earlier. The figure is a 20 percent increase from 3 billion won ($2.3 million) in the prev
Bayer, a prominent player in the pharmaceutical industry, is establishing itself as a trailblazer in radiology, as shown by its commitment and strategic moves aimed at driving innovation in medical imaging.With a robust performance, generating close to 2 billion euros ($2.1 billion) in sales from ra
JLK, a Kosdaq-listed medical AI company, has come under fire after its executives sold their shares. The company has apologized and promised to buy back and burn shares, but restoring trust isn't easy.According to the company’s public disclosure on Monday, JLK Vice Presidents Kang Shin-wook and Lee
Hugel announced Monday that it has recorded 84.8 billion won ($64 million) in sales, 34.6 billion won ($26.1 million) in operating profit and 41.6 billion won ($31.4 million) in net profit for the third quarter of 2023 based on consolidated financial statements.Sales and operating income grew 20 per
The simultaneous exposure of shift workers to long shifts and short breaks has a synergistic interaction and increases the risk of depression, a new study shows.Soon Chun Hyang University Hospital Seoul said Monday that a team led by Professor Lee June-hee of the Department of Occupational and Envir
Aptabio Therapeutics, a developer of intractable cancer and diabetes complications, announced Monday that it will present preclinical results on the effectiveness of its treatment for Parkinson's disease, APX-NEW, in animal models at the Society of Neuroscience (SFN).The SFN is a large-scale meeting